U.S. flag

An official website of the United States government

NM_058216.3(RAD51C):c.784T>G (p.Leu262Val) AND Malignant tumor of breast

Germline classification:
Uncertain significance (1 submission)
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001356788.3

Allele description [Variation Report for NM_058216.3(RAD51C):c.784T>G (p.Leu262Val)]

NM_058216.3(RAD51C):c.784T>G (p.Leu262Val)

Gene:
RAD51C:RAD51 paralog C [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
17q22
Genomic location:
Preferred name:
NM_058216.3(RAD51C):c.784T>G (p.Leu262Val)
Other names:
p.L262V:TTA>GTA
HGVS:
  • NC_000017.11:g.58709937T>G
  • NG_023199.1:g.22336T>G
  • NM_058216.3:c.784T>GMANE SELECT
  • NP_478123.1:p.Leu262Val
  • LRG_314t1:c.784T>G
  • LRG_314:g.22336T>G
  • NC_000017.10:g.56787298T>G
  • NM_058216.1:c.784T>G
  • NM_058216.2:c.784T>G
  • NR_103872.2:n.659T>G
  • O43502:p.Leu262Val
  • p.L262V
Protein change:
L262V
Links:
UniProtKB: O43502#VAR_068020; dbSNP: rs149331537
NCBI 1000 Genomes Browser:
rs149331537
Molecular consequence:
  • NM_058216.3:c.784T>G - missense variant - [Sequence Ontology: SO:0001583]
  • NR_103872.2:n.659T>G - non-coding transcript variant - [Sequence Ontology: SO:0001619]

Condition(s)

Name:
Malignant tumor of breast
Synonyms:
Malignant breast neoplasm; Cancer breast
Identifiers:
MONDO: MONDO:0007254; MedGen: C0006142

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001552053Department of Pathology and Laboratory Medicine, Sinai Health System - The Canadian Open Genetics Repository (COGR)

See additional submitters

no assertion criteria provided
Uncertain significanceunknownclinical testing

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedunknownyesnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From Department of Pathology and Laboratory Medicine, Sinai Health System - The Canadian Open Genetics Repository (COGR), SCV001552053.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

The RAD51C p.Leu262Val variant was identified in 6 of 12090 proband chromosomes (frequency: 0.001) from individuals or families with breast and ovarian cancer and was present in 1 of 4854 control chromosomes (frequency: 0.0002) from healthy individuals (Jonson 2015, Song 2015, Thompson 2012). The variant was also identified in the following databases: dbSNP (ID: rs149331537) as With Uncertain significance allele, ClinVar (classified as uncertain significance by GeneDx, Ambry Genetics, Invitae, Counsyl, Color Genomics), and LOVD 3.0 (2X). The variant was not identified in the Cosmic or MutDB databases. The variant was identified in control databases in 19 of 277192 chromosomes at a frequency of 0.000069 (Genome Aggregation Database Feb 27, 2017). Breakdown of the observations by population include African in 1 of 24034 chromosomes (freq: 0.00004), Other in 1 of 6466 chromosomes (freq: 0.0002), European Non-Finnish in 16 of 126684 chromosomes (freq: 0.0001), European Finnish in 1 of 25790 chromosomes (freq: 0.00004), while the variant was not observed in the Latino, Ashkenazi Jewish, East Asian, and South Asian populations. The p.Leu262 residue is conserved across mammals and other organisms, and four out of five computational analyses (PolyPhen-2, SIFT, AlignGVGD, BLOSUM, MutationTaster) suggest that the p.Leu262Val variant may impact the protein; however, this information is not predictive enough to assume pathogenicity. The variant occurs outside of the splicing consensus sequence and 5 of 5 in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer, HumanSpliceFinder) predict a greater than 10% difference in splicing. However, this information is not predictive enough to assume pathogenicity. In addition, Human Splicing Finder (HSF) splice analysis showed the possible introduction of a cryptic donor site caused by c.784T>G (Thompson 2012). In summary, based on the above information, the clinical significance of this variant cannot be determined with certainty at this time. This variant is classified as a variant of uncertain significance.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownyesnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Apr 20, 2025